Poolbeg Pharma says research confirms $10B plus opportunity for POLB 001 in cancer immunotherapies

By Proactive Investors / February 12, 2024 / www.youtube.com / Article Link

Poolbeg Pharma Plc chief business officer David Allmond joined Proactive's Stephen Gunnion with details of independent ...

Recent News

Big Gold production declining, revenue surging, costs flat

February 23, 2026 / www.canadianminingreport.com

Gold stocks rise with majors outpaced by juniors

February 23, 2026 / www.canadianminingreport.com

Agnico Eagle's production dip and higher costs offset by jump in gold

February 17, 2026 / www.canadianminingreport.com

Barrick, Agnico Eagle report extremely strong Q4/25 results

February 17, 2026 / www.canadianminingreport.com

Metals far outpacing tech over past year

February 09, 2026 / www.canadianminingreport.com

See all >